Jonathan Black, MD
Allergy & Immunology · Columbia, SCNPI 1659588382
Payments from drug & device makers
Across 412 payments — averaging $22.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$2K
- AstraZeneca$975
- Octapharma USA, Inc.$761
- CSL Behring$752
- GSK$711
- Biocryst US Sales Co., LLC$611
- plus $4K from 34 others
What the payments were for
- Food & beverage$8,97796%
- Education$3464%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 52 | $1,579 |
| AstraZeneca | 51 | $975 |
| Octapharma USA, Inc. | 13 | $761 |
| CSL Behring | 37 | $752 |
| GSK | 42 | $711 |
| Biocryst US Sales Co., LLC | 23 | $611 |
| Regeneron Healthcare Solutions, Inc. | 21 | $548 |
| Optinose US, Inc. | 14 | $427 |
| Novartis | 17 | $335 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $325 |
| Genentech USA, Inc. | 15 | $323 |
| Grifols USA, LLC | 12 | $217 |
| Pfizer | 16 | $216 |
| AbbVie | 9 | $185 |
| Amgen | 8 | $169 |
| Alk-abello, Inc | 9 | $160 |
| Pharming Healthcare, Inc. | 5 | $118 |
| Galderma Laboratories, L.p. | 7 | $117 |
| Boehringer Ingelheim | 7 | $115 |
| Hospira, Inc. | 5 | $91 |
| Kaleo, Inc. | 4 | $76 |
| Ionis Pharmaceuticals, Inc. | 3 | $64 |
| Aimmune Therapeutics, Inc. | 4 | $61 |
| Teva Pharmaceuticals USA, Inc. | 5 | $60 |
| Merck | 3 | $44 |
| Aytu Biopharma, Inc. | 2 | $34 |
| Organon | 2 | $28 |
| Incyte Corporation | 1 | $27 |
| Cycle Pharmaceuticals Inc | 1 | $21 |
| Biocryst Pharmaceuticals, Inc. | 1 | $20 |
| Phadia US Inc. | 1 | $17 |
| Blueprint Medicines Corporation | 1 | $17 |
| Mylan Specialty L.p. | 1 | $17 |
| Covis Pharma GmbH | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| EMD Serono, Inc. | 1 | $15 |
| LEO Pharma Inc. | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Seqirus USA Inc | 1 | $14 |
| Eyevance Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,323 in reported general payments places this provider in the 55th percentile of 46 allergy & immunology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 88 | $83,665 |
| Dupixent SyringeDupilumab | 22 | $83,088 |
| Breo ElliptaFluticasone/Vilanterol | 96 | $49,896 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $20,817 |
| SymbicortBudesonide/Formoterol Fumarate | 48 | $16,294 |
| Arnuity ElliptaFluticasone Furoate | 36 | $16,006 |
| Qvar RedihalerBeclomethasone Dipropionate | 40 | $13,998 |
| Epinephrine | 69 | $11,357 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 25 | $9,380 |
| XhanceFluticasone Propionate | 12 | $7,780 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 29 | $7,428 |
| Ipratropium Bromide | 123 | $6,216 |
| Wixela InhubFluticasone Propion/Salmeterol | 28 | $5,357 |
| Fluticasone Propionate | 242 | $5,188 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 179 | $4,627 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $711 | $149,566220 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $975 | $37,11169 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $60 | $13,99840 claims |
| Hikma Pharmaceuticals USAEpinephrine | $15 | $11,35769 claims |
| Optinose US, Inc.Xhance | $427 | $7,78012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 46 allergy & immunology providers in South Carolina.
Other allergy & immunology in Columbia
- David AmrolColumbia$172K
- Michael BykowskyColumbia$4K
- Lisa HuttoColumbia$1K
- David PerrickColumbia$1K
- Robert Vande StouweColumbia$284
- John RameyNorth Charleston$1.5M
- Thomas MurphyCharleston$1.4M
- Douglas JohnstonGreenville$1.3M
- Patricia GerberNorth Charleston$970K
- Ned RuppNorth Charleston$861K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.